KT&G Corp
KRX:033780
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
95 000
147 200
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
KT&G Corp
KT&G Corp., an acronym for Korea Tobacco & Ginseng Corporation, is a unique entity in the global business landscape, epitomizing a fascinating blend of tradition and modernity. Born in South Korea, KT&G has transcended its origins to become a formidable player in both the tobacco and health supplement industries. Its roots stretch back to 1899 when it began as a state-run monopoly in Korea focusing on tobacco. Over the decades, it has successfully evolved, strategically privatizing its operations in 2002. Today, KT&G is a publicly traded company that has successfully diversified its portfolio by expanding into the fields of cosmetics and biotechnology, though tobacco and ginseng remain its flagship products. Its prowess lies in understanding the delicate balance between sectors that are not typically seen together: the addictive allure of tobacco and the wellness attributes of Korean ginseng.
The financial engine of KT&G is primarily fueled by its tobacco division, which produces a vast array of cigarette brands that cater to varying consumer preferences across the globe. This segment is a powerhouse, with products that are distributed in over 50 countries, ensuring a steady stream of revenue. On the other hand, the ginseng business is another pillar of KT&G's economic structure, driven by the growing global demand for natural health supplements, including its renowned CheongKwanJang brand, which has become synonymous with quality and reliability in ginseng products. This dual approach enables KT&G to mitigate risks associated with each industry's specific challenges, creating a robust and diversified revenue model. It's a strategic maneuver allowing KT&G to capitalize on the burgeoning wellness trend while maintaining its dominant position in the tobacco market.
KT&G Corp., an acronym for Korea Tobacco & Ginseng Corporation, is a unique entity in the global business landscape, epitomizing a fascinating blend of tradition and modernity. Born in South Korea, KT&G has transcended its origins to become a formidable player in both the tobacco and health supplement industries. Its roots stretch back to 1899 when it began as a state-run monopoly in Korea focusing on tobacco. Over the decades, it has successfully evolved, strategically privatizing its operations in 2002. Today, KT&G is a publicly traded company that has successfully diversified its portfolio by expanding into the fields of cosmetics and biotechnology, though tobacco and ginseng remain its flagship products. Its prowess lies in understanding the delicate balance between sectors that are not typically seen together: the addictive allure of tobacco and the wellness attributes of Korean ginseng.
The financial engine of KT&G is primarily fueled by its tobacco division, which produces a vast array of cigarette brands that cater to varying consumer preferences across the globe. This segment is a powerhouse, with products that are distributed in over 50 countries, ensuring a steady stream of revenue. On the other hand, the ginseng business is another pillar of KT&G's economic structure, driven by the growing global demand for natural health supplements, including its renowned CheongKwanJang brand, which has become synonymous with quality and reliability in ginseng products. This dual approach enables KT&G to mitigate risks associated with each industry's specific challenges, creating a robust and diversified revenue model. It's a strategic maneuver allowing KT&G to capitalize on the burgeoning wellness trend while maintaining its dominant position in the tobacco market.
Record Performance: KT&G posted its highest ever quarterly revenue and operating profit, driven by robust global cigarette (CC) growth and strong results across tobacco, real estate, and health functional foods.
Guidance Raised: Management increased full-year 2025 guidance, now expecting revenue to grow above 10% (previously 5–7%) and operating profit to increase by more than 12% (previously 6–8%).
Global CC Momentum: The global CC business achieved double-digit growth in both volume and average selling price (ASP), with Q3 revenue up 25% year-on-year, marking a third consecutive record quarter.
FX Impact: Net profit surged 73.4% year-on-year, mainly due to significant foreign exchange gains from currency fluctuations.
Nicotine Pouch Expansion: KT&G signed a partnership with Altria to jointly acquire Another Snus Factory (ASF) and plans global expansion of nicotine pouch products starting next year.
Cost Improvements: Company saw stabilized costs for non-tobacco materials and a notable year-on-year decrease in imported leaf costs, with further cost savings expected from new global production sites.
CapEx and Production: Kazakhstan and Indonesian plants ramping up, with global facilities expected to produce about 50% of total volume; CapEx expected to stabilize at KRW 200–300 billion.
NGP and HFF Updates: NGP revenue rose around 45% on strong device and stick sales, while HFF profit grew despite revenue pressure; focus remains on high-profit channels and international expansion.